Meeting highlights from the PRAC 2326 October 2023 GLP-1 receptor agonists: available evidence not supporting link with thyroid cancer
#Diabetes #HealthcareInnovation #Pharma #GLP1 #MedicalAffairs #HealthTech #DigitalHealth #PrecisionMedicine #ObesityMedicine #PharmD #ClinicalResearch #PharmaniMedX To view or add a comment, sign in Elecoglipron Lowers HbA1c by 1.9% and Drives Weight Loss in Phase 2b Studies Phase 2b clinical data show that elecoglipron achieved HbA1c reductions of up to 1.9% while delivering meaningful weight loss in adults with type 2 diabetes and obesity
Retatrutide targets three metabolic receptors for fat oxidation, insulin sensitivity, and body recomposition
[39] Brachytherapy as a treatment for uveal melanoma was led by Packer [40] , who described sewing a customized plaque containing the radioisotope iodine-125, over the region affected by the tumor
GLP-1 Weight Loss & Menopause: Looking Beyond the Scales Weight gain during menopause is often far more complex than simply "eating less and moving more." Hormonal changes can influence appetite regulation, insulin sensitivity, body composition, sleep quality, energy levels, and muscle mass, all of which can make weight management more challenging during midlife
